Get Ready Big Blue Is Coming

All aboard the Pfizer express - its a fun ride for all!

 

It's over. They've moved on. Let it go!

 

Ya you can tell
By the stock price it's over! So please move on your boring the shit out me.

 

Oh great... This again.

 

Sorry to disappoint you, but ain't gonna happen.

 

Get ready my fellow AZ people! We're about to be ass raped by big blue....

 

Only in your wet dreams.

 

Frenchie's ego is WAY to big to lose his CEO title! That's why he turned down Pfizer's incredible offer. Now the idiot is predicting $45 billion in sales in a few years! He is delusional..but what do you expect, he's French!

 

What an idiot you are. The business analysts, bankers, etc have repeatedly stated 10-20% chance at best. They have zero interest in AZ and their actions recently have backed it up with investment/collaboration with Merck. There's no price point at which Soriot Or top shareholders will agree to. Made that crystal clear.

 

They make him CEO of bigger company. He'll then have the az oncology assets plus the new stuff from pfizers Merck deal. Restructure a bit. Quite doable even without the tax inversion.

 

Hey tool- If even HALF of the products in phase II and III trials come to fruition, 45B in about 10 years is very attainable. While its true AZ has a history of failing to get products to market, you have to admit with the new regime, things are moving through and getting approved at a much faster rate. Naysay all you want, AZ has a much better chance of succeeding with the French guy steering this ship then the U.S. leaders did.

 

It will not be big Blue! Look for Sanofi and us to merge. Similar set up to our company being formed 15 years ago!!

 

Same troll posted over on Pfizer... I would never say never, but highly unlikely. When you look from multiple sides, odds are good that ship sailed back in May. The agreement between Pfizer and MerckKGA has specific language regarding either company from collaborating with anyone else on PDL-'s1 or any other drugs in that class. Not saying Pfizer couldn't simply payout Merck and come after AZ. Pascal and Board said they would have started talking at 58.50 when Pfizer offered 55. (Analysts/speculators are saying AZ would have accepted $58.50, in order to keep hope alive and keeping stock inflated) Back in August in a financial interview, Johanssen said that because one price was a starting price in May doesn't mean it is the same price today. Since May a great deal has happened, DOJ cleared up with Brilinta, New guidelines suggesting Brilinta utilization, Nexium lack of generic competition, Gout drug approved, respiratory deals and approvals in EU, Promising results in late phase trials for oncology drugs and psoriasis drug, Diabetes approvals, Sales higher than expected and other deals and acquisitions with smaller companies have probably driven up the price negotiations would need to start at. Driving starting price up. Compounded with the threat of US Treasury actions and upcoming elections in UK and the fact they upset the apple cart on both sides of the pond in May and in other M&A's in the past. Highly unlikely they want to risk loosing another bid with no major tax benefits. Investors would be calling for Reed's head if he failed a second time. Much easier to find willing partners at significantly lower prices. Don't be surprised if Pfizer goes after mid size such as Mylan, Merck KGA, etc..

 

OK fool. Where's your Pfizer takeover?


Pfizer deal probably 'would have fallen apart': AZ CEO 11/29/2014

Pfizer's attempt to gain control of U.K. pharmaceutical company AstraZeneca through a £69.4 billion ($110 billion) bid in May would have run aground on changes to U.S. tax inversion laws, the chief executive of AstraZeneca has told CNBC.

"We were worried about the tax inversion risk – in fact it has become a reality. If we had agreed to a deal at the time, probably that deal would have fallen apart by now, just like the AbbVie/Shire deal, and created enormous destruction and disruption in our company," Soriot told CNBC in an exclusive interview.

AbbVie's $54 billion offer for Shire was withdrawn in October after U.S. Treasury Secretary Jack Lew announced new rules aimed at stopping inversion-related deals. The controversial tax strategy involves companies moving their headquarters to another country to avoid paying U.S. tax on overseas income. Pfizer planned to move its corporate headquarters to the U.K. if it had been successful in its bid for AstraZeneca during the summer.

 

If they come, let them! We will beat them down again. Once more my friends into the breach!

 

Just FUCK OFF!

 

All Im saying is that we have heard NOTHING from Pfizer and Ian Read only the AZ CEO who seems scared and playing defense. If Read was not going to move beleive me he would say so. Wednesday passed without a word. I'm thinking next week they will make a move. Pfizer has had 6 months to plan for this, are good at it and hate to lose especially the second time around. The silence is why it will happen.

 

Pfizer doesn't give up once they have an idea. I think they would have made a bid somewhere by now if it wasn't AZ.

 

Pfizer was after the inversion. Tax laws were changed to make the inversion not financially worth it. It's why Abbvie/Shire fell apart, and why Pfizer is not coming back. They don't give two shits about AZ, it was all about the inversion, now that it's no longer possible, Pfizer will go back to not giving a shit about AZ

 

AZ was like a nice fresh carbonated beverage to Big Blue at first. Nice ,fresh, crisp taste at ...but loses its fizz after a while. Now Pfizer feels that ....AZ is nothing more than a flat blah bland unassuming beverage. Don't expect anything to return from the dead. This deal was dead a long time ago! Things will remain quiet on the merger/acquisition front lines for the near future.